T1	Participants 73 109	infants younger than 6 months of age
T2	Participants 122 136	Young children
T3	Participants 280 305	children <6 months of age
T4	Participants 398 406	children
T5	Participants 660 698	healthy children 6 to <24 weeks of age
T6	Participants 708 763	Healthy infants aged 6 to <16 weeks and 16 to <24 weeks
T7	Participants 1041 1068	infants aged 6 to <16 weeks
T8	Participants 1133 1159	hose aged 16 to <24 weeks,
T9	Participants 1222 1243	6- to <16-week cohort
T10	Participants 1499 1517	vaccine recipients
T11	Participants 1536 1549	placebo group
T12	Participants 1627 1657	children 6 to <16 weeks of age
T13	Participants 1734 1764	infants 6 to <24 weeks of age.
T14	Participants 1858 1880	fants <6 months of age
